Clik here to view.
Kristin Neuman将在NewYorkBIO和AIPLA上谈论MPEG LA的CRISPR专利池许可证
丹佛 (美国商业资讯)–全球许可领导者MPEG LA, LLC今天宣布，MPEG LA的生物技术许可执行总监Kristin Neuman将在NewYorkBIO和美国知识产权法协会(AIPLA)春季会议上发表演讲，这两项活动将分别于5月11日和5月17日在纽约市和圣地亚哥举行。届时，Neuman女士将探讨MPEG LA的CRISPR-Cas9联合许可平台(Joint Licensing...
View ArticleClik here to view.
クリスティン・ニューマンがNewYorkBIOとAIPLAでMPEG LAのCRISPRプールライセンスについて発題
デンバー （ビジネスワイヤ） — ライセンシングの世界的リーダー企業MPEG LAは本日、MPEG...
View ArticleClik here to view.
Avita Medical Announces Positive Results from Pivotal Trial
VALENCIA, Calif. & PERTH, Australia Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today said it achieved both...
View ArticleClik here to view.
Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the...
LYON, France POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced...
View ArticleClik here to view.
Avita Medical’s Board Show Confidence in Company by Taking Payment in Shares
NORTHRIDGE, Calif. & PERTH, Australia & CAMBRIDGE, England The board of pioneering regenerative medicine company Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY), have shown a strong vote of...
View ArticleClik here to view.
Upside Biotechnologies to Work with US Army on Engineered Skin Replacement
AUCKLAND, New Zealand Regenerative medicine start-up Upside Biotechnologies has signed a CRADA (Cooperative Research and Development Agreement) with the US Army Medical Research and Materiel Command...
View ArticleClik here to view.
Dr Michael S. Perry Appointed Avita Medical CEO
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England The board of pioneering regenerative medicine company Avita Medical Limited (ASX: AVH; OTCQX: AVMXY) has appointed Dr Michael (Mike)...
View ArticleClik here to view.
Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy...
LJUBLJANA, Slovenia PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of the Fetal Medicine Foundation’s (FMF’s) Project “ASPRE” study...
View ArticleClik here to view.
サンバイオ：カリフォルニア州再生医療機構（CIRM）から脳梗塞フェーズ2b臨床試験に20百万米ドルの補助金を獲得
東京 （ビジネスワイヤ） — サンバイオ株式会社（本社：東京都中央区、代表取締役社長：森 敬太）は、本日、米国で実施している再生細胞薬SB623（以下、「本剤」）の慢性期脳梗塞を対象としたフェーズ2b臨床試験（以下、「本試験」）に対して、カリフォルニア州再生医療機構（CIRM）から20百万米ドルの補助金を獲得しましたので、お知らせいたします。...
View ArticleClik here to view.
麻省理工学院和哈佛大学旗下博德研究所等机构加入MPEG LA的CRISPR-Cas9联合授权推广项目
丹佛 (美国商业资讯)–全球授权领军企业MPEG LA, LLC欣然宣布，主要的CRISPR专利所有者已提交专利，以响应MPEG LA参加打造国际化CRISPR-Cas9联合授权平台的呼吁。同时，MPEG LA, LLC仍将继续接受专利提交。 MPEG LA总裁兼首席执行官Larry Horn表示，“对MPEG...
View ArticleClik here to view.
MITとハーバード大学のブロード研究所がMPEG LAのCRISPR-Cas9共同ライセンシングを促進する組織の一角を占める
デンバー （ビジネスワイヤ） — ライセンシングの世界的リーダー企業MPEG LAは、重要なCRISPR特許保有者が世界的なCRISPR-Cas9共同ライセンシングプラットフォーム創設へのMPEG LAによる参加呼び掛けに応えて特許を提出し、提出特許の受理が続けられていることを発表します。 MPEG LA社長兼最高経営責任者（CEO）のラリー・ホーンは、次のように述べています。｢MPEG...
View ArticleClik here to view.
Avita Medical CEO Issues Shareholder Letter
VALENCIA, Calif. & PERTH, Australia & LONDON Today, the CEO of Avita Medical Limited (ASX:AVH) (OTCQX:AVMXY) issued the following letter to shareholders: Dear Shareholder, It is with great...
View ArticleClik here to view.
SpinalCyteが新たな日本国特許を取得
ヒューストン テキサスに拠点を置き、ヒト皮膚線維芽細胞を使用した椎間板髄核の再生に傾注する組織工学技術企業のSpinalCyte, LLCは本日、日本国特許第6151006号「生体内バイオリアクターを使用した軟骨修復のための方法と組成物」の登録を発表しました。...
View ArticleClik here to view.
Yamaha Motor Releases the Cell Picking & Imaging System CELL HANDLER(TM)
IWATA, Japan Yamaha Motor Co., Ltd. (TOKYO:7272) (ISIN:JP3942800008) announced today that it has developed the cell picking/imaging system CELL HANDLERTM. This device performs part of the testing...
View ArticleClik here to view.
ImmusanT Presents Data from Multiple Studies Supporting Continued Development...
CAMBRIDGE, Mass. ImmusanT, Inc., a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet...
View ArticleClik here to view.
Research Definitively Confirms Superiority of ReCell® for Treatment of Burn...
VALENCIA, Calif. & PERTH, Australia & LONDON The ReCell® Autologous Cell Harvesting Device effectively reduces the amount of skin harvesting required relative to conventional treatment of...
View ArticleClik here to view.
SanBio Names Mohammad El-Kalay New Technical Operations SVP
MOUNTAIN VIEW, Calif. SanBio, Inc., a leader in regenerative cell therapies, today announced the appointment of Mohammad El-Kalay, PhD, as Senior Vice President of Technical Operations. In this...
View ArticleClik here to view.
Avita Medical Announces Submission of U.S. FDA Premarket Approval (PMA)...
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced...
View ArticleClik here to view.
Promethera Biosciences and Shibuya Announce Strategic Collaboration to...
MONT-SAINT-GUIBERT, Belgium & KANAZAWA, ISHIKAWA, Japan Promethera Biosciences SA, a global innovator in cell-based medicines, and Shibuya Corporation (6340:Tokyo Stock Exchange) announced today...
View ArticleClik here to view.
Avita Medical A$16.9 Million Capital Raising
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specialising in the treatment of wounds and skin defects, is undertaking...
View Article